# Effects of Ketosis on Muscle Kinetics and Signaling During Critical Illness.

> **NCT05074862** · PHASE2 · UNKNOWN · sponsor: **Aarhus University Hospital** · enrollment: 10 (estimated)

## Conditions studied

- Intensive Care Unit Acquired Weakness
- Critical Illness

## Interventions

- **DIETARY_SUPPLEMENT:** KetoneAid KE4 Pro Monoester
- **DIETARY_SUPPLEMENT:** Maltodextrin and fat-based placebo

## Key facts

- **NCT ID:** NCT05074862
- **Lead sponsor:** Aarhus University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-01-01
- **Primary completion:** 2023-06-01
- **Final completion:** 2023-12-01
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2022-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05074862

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05074862, "Effects of Ketosis on Muscle Kinetics and Signaling During Critical Illness.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05074862. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*